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Depression during pregnancy and in the postpartum period is common, devastating to mothers and their
offspring, and poorly understood in terms of pathophysiology. In this issue of Neuron, Maguire and Mody
provide evidence for a role for aberrant neurosteroid regulation of the GABAA receptor subunit in the etiology
of postpartum depression, presaging elucidation of the pathophysiology and development of treatments of
this depression endophenotype.There is increasing attention in all
branches of medicine to elucidation of
pathophysiologically distinct subtypes of
syndromes ranging from diabetes and
cardiomyopathies to cerebrovascular
accidents (stroke) and mood disorders
(Craddock et al., 2008). Elucidation of
such endophenotypes is essential to iden-
tify their unique pathophysiology and
thereby develop novel treatment strate-
gies. At the present time, patients who
fulfill criteria for major depression are gen-
erally treated by a trial and error method
with psychotherapy or antidepressants
(or both) previously shown to be effective,
irrespective of the depressive subtype.
Currently, with a few exceptions such as
depression with psychotic features (Nem-
eroff, 2006), there is insufficient data to
drive clinical decision-making as to which
particular antidepressant,moodstabilizer,
or psychotherapeutic method is best
suited for any depressive subtype, much
less for any individual patient. This likely
explains why largescale clinical trials
have revealed remission rates in the acute
treatment of major depression of approxi-
mately 28%–40% (Nemeroff et al., 2008),
which are clearly less than optimal.
Although there is considerable evi-
dence for a preeminent role for three
monoamine systems, serotonin (5HT),
norepinephrine (NE), and dopamine (DA),
in the pathogenesis of depression, de-
pression clearly involves other circuits
including neuropeptide systems such as
corticotropin-releasing factor (CRF) and
glutamate and GABA circuits (Ressler
and Nemeroff, 2007; Kasa et al., 1982).Depression during pregnancy and in
the postpartum period is an area of
much needed research, in terms of both
pathophysiology and treatment. Women
are more than twice as susceptible to
depression as men (Kessler et al., 2005),
and in spite of the popular notion that
pregnancy protects against depression,
it does not. Rates of depression during
pregnancy are not lower than in the
nonpregnant state, approximately 14%–
20% (Oberlander et al., 2006), and post-
partum depression defined as depression
within one year of delivery is very com-
mon, affecting 10%–22% of adult
women, with higher rates in adolescent
women (Kendler et al., 1993). It is impor-
tant to note that there is increasing
evidence that depression during preg-
nancy and in the postpartum period has
adverse effects, both physiological and
behavioral, on their offspring (Gluckman
et al., 2008). Because of the concerns of
women and their healthcare providers
about the potential adverse effects of psy-
chotropic medications on the fetus and
newborn (via breastfeeding) if prescribed
during pregnancy or during the postpar-
tum period, respectively, the calculation
of risk-benefit ratios is of paramount
importance. In essence, depriving women
during pregnancy and in the puerperium
from psychopharmacological treatment
for mood disorders increases the risk
of suicide, infanticide, drug and alcohol
abuse, and malnutrition (Stowe and
Nemeroff, 1995), as well as disrupts the
mother-infant relationship during a critical
period in child development. However,Neurotreatment of women during pregnancy or
in the postpartum period exposes their
offspring to psychotropic medication
which may have adverse side effects.
One major impediment to advances in
mood disorders research has been a rela-
tive lack of animal models of depression,
as opposed, for example, to animal
models of anxiety disorders (Arborelius
and Nemeroff, 2002) or substance abuse
(Koob and Le Moal, 2006). Moreover, it is
well established that, on average, the risk
for the development of major depression
is approximately one-third genetic and
two-thirds environmental. Major ad-
vances in basic research in genetics and
molecular neurobiology have, of course,
largely utilizedmice, whereas the vastma-
jority of animal models of psychiatric dis-
orders have, in contrast, utilized rats. The
report in this issue of Neuron by Maguire
and Mody (2008) on GABAA receptor
(GABAAR) plasticity during pregnancy
and its implications for the pathophysiol-
ogy of postpartum depression likely re-
presents an incremental breakthrough in
the field. They demonstrate that in mice
GABAARexpression ismarkedlydownreg-
ulated by the increase in progesterone-
derived neurosteroids during pregnancy,
an effect which rebounds rapidly in the
postpartum period. After demonstrating
reductions in GABAAR subunit expression
in the hippocampus in mice during preg-
nancy and the functional consequences
by whole-cell patch-clamp recordings,
studies were conducted in mice that do
not exhibit GABAAR subunit regulation
(Gabrd+/ and Gabrd/). Remarkably,n 59, July 31, 2008 ª2008 Elsevier Inc. 185
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exhibited marked depressive-like behav-
ior in standardized rodent models of de-
pression, namely the Porsolt forced swim
test, and in a standardized laboratory
test of anhedonia, a cardinal symptom of
depression. In addition, and uncannily rel-
evant to the small but significant increase
in infanticide in women with postpartum
depression, was a significant increase in
pup mortality in the GABAAR d subunit
knockout mice due to maternal neglect
and cannibalism. Most impressive is the
reversal of these behavioral alterations
by treatment with the GABAAR d-sub-
unit-selective agonist THIP.
The implications of this research are
considerable and it suggests several fu-
ture research directions. Functional brain
imaging studies could elucidate GABA
and GABAAR alterations in depressed
women during pregnancy or postpartum
using magnetic resonance spectroscopy
(MRS) and PET imaging, respectively.
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synapses.
It has long been known that synapse for-
mation involves movement of both future
presynaptic axons and postsynaptic den-
drites, particularly movement of dendritic
filopodia (Ziv and Smith, 1996; Jontes
and Smith, 2000; Lohmann et al., 2002).
This reciprocal movement leads to physi-
cal contact between the two cells, which
can yield mature synaptic connections if
these contacts are stabilized and subse-
186 Neuron 59, July 31, 2008 ª2008 Elseviepolymorphisms of the GABAAR or other
components of the GABA system predict
vulnerability to postpartum depression.
Finally, treatment studies with THIP or re-
lated molecules in postpartum depres-
sion would surely be of interest.
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The experiments described in this
paper used dynamic fluorescent imaging
of multiple neurons in cultured hippo-
campal slices to watch how dendritic
filopodia form contacts with axons. Pre-
synaptic axons were labeled by a green
calcium indicator dye or by GFP-labeled
GAD65 or synaptophysin, while individual
